These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25044085)

  • 21. Enclomiphene, an estrogen receptor antagonist for the treatment of testosterone deficiency in men.
    Hill S; Arutchelvam V; Quinton R
    IDrugs; 2009 Feb; 12(2):109-19. PubMed ID: 19204885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Randomized Prospective Double-Blind Comparison Trial of Clomiphene Citrate and Anastrozole in Raising Testosterone in Hypogonadal Infertile Men.
    Helo S; Ellen J; Mechlin C; Feustel P; Grossman M; Ditkoff E; McCullough A
    J Sex Med; 2015 Aug; 12(8):1761-9. PubMed ID: 26176805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LH and non-SHBG testosterone and estradiol levels during testosterone replacement of hypogonadal men: further evidence that steroid negative feedback increases as men grow older.
    Winters SJ; Wang C;
    J Androl; 2010; 31(3):281-7. PubMed ID: 19959827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
    Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ
    J Androl; 1998; 19(6):761-8. PubMed ID: 9876028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open-label, phase 2, single centre, randomized, crossover design bioequivalence study of AndroForte 5 testosterone cream and Testogel 1% testosterone gel in hypogonadal men: study LP101.
    Wittert GA; Harrison RW; Buckley MJ; Wlodarczyk J
    Andrology; 2016 Jan; 4(1):41-5. PubMed ID: 26754331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
    Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
    Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center study.
    Salehian B; Wang C; Alexander G; Davidson T; McDonald V; Berman N; Dudley RE; Ziel F; Swerdloff RS
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3567-75. PubMed ID: 8530600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome.
    Radicioni AF; Di Giorgio G; Grugni G; Cuttini M; Losacco V; Anzuini A; Spera S; Marzano C; Lenzi A; Cappa M; Crinò A
    Clin Endocrinol (Oxf); 2012 Jan; 76(1):72-7. PubMed ID: 21718342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone enanthate.
    Anderson RA; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):896-901. PubMed ID: 8772547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Semen parameters and hormonal profile in obese fertile and infertile males.
    Hofny ER; Ali ME; Abdel-Hafez HZ; Kamal Eel-D; Mohamed EE; Abd El-Azeem HG; Mostafa T
    Fertil Steril; 2010 Jul; 94(2):581-4. PubMed ID: 19423100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study.
    Hussein A; Ozgok Y; Ross L; Rao P; Niederberger C
    BJU Int; 2013 Mar; 111(3 Pt B):E110-4. PubMed ID: 22958644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The beneficial effects of toremifene administration on the hypothalamic-pituitary-testicular axis and sperm parameters in men with idiopathic oligozoospermia.
    Farmakiotis D; Farmakis C; Rousso D; Kourtis A; Katsikis I; Panidis D
    Fertil Steril; 2007 Oct; 88(4):847-53. PubMed ID: 17412336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone and gonadotropin levels in men with dementia.
    Hogervorst E; Combrinck M; Smith AD
    Neuro Endocrinol Lett; 2003; 24(3-4):203-8. PubMed ID: 14523358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of male hypogonadism with testosterone enanthate.
    Snyder PJ; Lawrence DA
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1335-9. PubMed ID: 6777395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism.
    Schubert M; Minnemann T; Hübler D; Rouskova D; Christoph A; Oettel M; Ernst M; Mellinger U; Krone W; Jockenhövel F
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5429-34. PubMed ID: 15531493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
    Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of testosterone gel treatment on spermatogenesis in men with hypogonadism.
    George M; Yulia T; Svetlana K
    Gynecol Endocrinol; 2014 Oct; 30 Suppl 1():22-4. PubMed ID: 25200823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol.
    Bagatell CJ; Dahl KD; Bremner WJ
    J Androl; 1994; 15(1):15-21. PubMed ID: 8188534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial reversal of the hypogonadotropic hypogonadism of obese men by administration of corticosuppressive doses of dexamethasone.
    Zumoff B; Strain GW; Miller LK; Rosner W; Levit CD; Miller EH; Rosenfeld RS
    Int J Obes; 1988; 12(6):525-31. PubMed ID: 3148562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.
    Swerdloff RS; Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Longstreth J; Berman N
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4500-10. PubMed ID: 11134099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.